MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt
· Delayed Price · Currency is EGP 238.57
+3.59 (1.53%)
At close: Aug 14, 2025
MINAPHARM Pharmaceuticals Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 194.45 | 157.07 | -31.99 | 612.66 | 466.41 | 300.78 | Upgrade
|
| Depreciation & Amortization | 308.61 | 284.71 | 192.23 | 132.86 | 85.99 | 82.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 5.67 | 5.67 | 0.17 | - | -0.46 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 36.99 | 39.15 | 12.64 | -2.67 | -8.91 | 7.29 | Upgrade
|
| Other Operating Activities | 139.82 | 159.72 | -88.92 | 81.64 | 90.93 | 63.48 | Upgrade
|
| Change in Accounts Receivable | -331.19 | -271.35 | -147.28 | -168.51 | -22.41 | -81.04 | Upgrade
|
| Change in Inventory | -40.93 | -180.96 | -226.43 | -171.08 | -83.29 | -101.36 | Upgrade
|
| Change in Accounts Payable | 162.55 | 265.8 | 39.82 | 265.15 | -91.57 | 208.89 | Upgrade
|
| Change in Other Net Operating Assets | -463.27 | -238.28 | 352.1 | -188.28 | -229.4 | -43.82 | Upgrade
|
| Operating Cash Flow | 12.69 | 221.51 | 102.34 | 561.77 | 207.28 | 437.13 | Upgrade
|
| Operating Cash Flow Growth | -86.68% | 116.44% | -81.78% | 171.03% | -52.58% | 112.40% | Upgrade
|
| Capital Expenditures | -866.09 | -918.96 | -1,395 | -1,160 | -387.87 | -150.29 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.17 | - | 0.76 | 0.11 | Upgrade
|
| Sale (Purchase) of Intangibles | -0 | -0.09 | -10.65 | -2.03 | -1.82 | -3.13 | Upgrade
|
| Other Investing Activities | 26.47 | 45.26 | 0 | 0 | -0.01 | 5.77 | Upgrade
|
| Investing Cash Flow | -539.62 | -573.79 | -1,405 | -1,162 | -388.94 | -147.55 | Upgrade
|
| Short-Term Debt Issued | - | 2,496 | 1,020 | 494.8 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 1,380 | 459.34 | 636.62 | 425.73 | 119.24 | Upgrade
|
| Total Debt Issued | 3,515 | 3,876 | 1,479 | 1,131 | 425.73 | 119.24 | Upgrade
|
| Short-Term Debt Repaid | - | -2,227 | - | - | -205.3 | -49.74 | Upgrade
|
| Long-Term Debt Repaid | - | -292.72 | -128.71 | -12.15 | -11.86 | - | Upgrade
|
| Total Debt Repaid | -3,612 | -2,520 | -128.71 | -12.15 | -217.16 | -49.74 | Upgrade
|
| Net Debt Issued (Repaid) | -97.61 | 1,356 | 1,350 | 1,119 | 208.57 | 69.5 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -69.63 | - | - | Upgrade
|
| Common Dividends Paid | -40.19 | -40.16 | -53.87 | -57.79 | -49.8 | -88.23 | Upgrade
|
| Other Financing Activities | -5.61 | - | -0.08 | 2.31 | -3.2 | -8 | Upgrade
|
| Financing Cash Flow | -143.4 | 1,316 | 1,296 | 994.16 | 155.57 | -26.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 25.76 | 5.49 | 230.86 | 317.88 | -13.97 | -10.38 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -1.5 | - | Upgrade
|
| Net Cash Flow | -644.58 | 969.43 | 224.34 | 711.56 | -41.56 | 252.48 | Upgrade
|
| Free Cash Flow | -853.4 | -697.45 | -1,292 | -598.45 | -180.6 | 286.84 | Upgrade
|
| Free Cash Flow Margin | -13.57% | -12.31% | -33.21% | -16.53% | -6.01% | 12.15% | Upgrade
|
| Free Cash Flow Per Share | -77.13 | -63.04 | -116.81 | -52.16 | -14.69 | 23.33 | Upgrade
|
| Cash Interest Paid | 694.83 | 593.68 | 254.46 | 62.17 | 48.84 | 69.3 | Upgrade
|
| Cash Income Tax Paid | 104.25 | 26.07 | 132.95 | 182.39 | 154.77 | 63.23 | Upgrade
|
| Levered Free Cash Flow | -233.19 | -422.87 | -1,289 | -622.61 | -139.42 | 277.3 | Upgrade
|
| Unlevered Free Cash Flow | 201.08 | -51.82 | -1,130 | -583.75 | -108.9 | 320.61 | Upgrade
|
| Change in Working Capital | -672.84 | -424.79 | 18.21 | -262.72 | -426.67 | -17.33 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.